Hydralazine Hydrochloride
NDC 68071-5285, Hydralazine Hydrochloride, tablet, from NuCare Pharmaceuticals,Inc..
- Product NDC
- 68071-5285
- Status
- Listed
- Labeler
- NuCare Pharmaceuticals,Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040901
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68071-5285 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDRALAZINE HYDROCHLORIDE100 mg/1
Pharmacologic classes
Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68071-5285-1 | 68071528501 | 100 TABLET in 1 BOTTLE (68071-5285-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a862321d-ebc1-7676-e053-2995a90a5861
Use it
Look up 68071-5285 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68071-5285 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68071-5285. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.